Predictors of comprehensive stimulation program efficacy in patients with cognitive impairment. Clinical practice recommendations

International Journal of Geriatric Psychiatry
Giuliano BinettiLuisa Benussi

Abstract

The aim of the present study was to identify which factors may predict the best response to a comprehensive stimulation program in patients with dementia and mild cognitive impairment (MCI) as well as in their caregivers. A six-month longitudinal study has been performed on 145 patients (55 with MCI and 90 with dementia), participating to a cognitive motor rehabilitation program, and their 131 caregivers, attending informational/psychoeducational interventions. Mini mental state examination, Alzheimer's Disease Assessment Scale-Cognition, and Clinician's Interview-Based Impression of Change-plus were used as primary outcome measures. Sixty-eight (46.9%) of the 145 subjects were classified as clinical responders. At baseline, responders had a significant less insight impairment, larger functional ability as well as less delusions, euphoria, and aberrant motor behaviors than the non-responder. After 6 months along with an improvement in cognition, responders showed decrease in behavioral disturbances and severity of the disturbances. During the 6 months of analysis, stability has been observed in caregiver's burden distress. After 6 months, the caregivers of MCI responders have their burden reduced. The high level of insight, the...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
May 1, 1992·Clinics in Geriatric Medicine·S I Kramer, B V Reifler
Dec 1, 1989·The Gerontologist·M Novak, C Guest
Jan 1, 1970·The Gerontologist·S KatzR C Grotz
Jul 1, 1966·The Annals of Thoracic Surgery·D M SensenigJ L Ehrenhaft
Nov 1, 1984·The American Journal of Psychiatry·W G RosenK L Davis
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Jan 1, 1995·Alzheimer Disease and Associated Disorders·O ZanettiM Trabucchi
Jan 1, 1996·Journal of Neurology, Neurosurgery, and Psychiatry·G BinettiM Trabucchi
Apr 30, 1998·Archives of Neurology·G BinettiJ L Cummings
Feb 23, 1999·Dementia and Geriatric Cognitive Disorders·G B FrisoniJ L Cummings
Mar 27, 1999·Brain : a Journal of Neurology·R J Perry, J R Hodges
Mar 31, 1999·The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences·O ZanettiM Trabucchi
Sep 6, 2001·International Journal of Geriatric Psychiatry·L P De VreeseO Zanetti
Dec 26, 2001·Archives of Neurology·R C PetersenB Winblad
May 15, 2002·Age and Ageing·Bob Woods
May 15, 2002·Age and Ageing·Orazio ZanettiLuc P De Vreese
Sep 2, 2003·The British Journal of Psychiatry : the Journal of Mental Science·Aimee SpectorMartin Orrell
Jun 19, 2004·Journal of Clinical and Experimental Neuropsychology·Linda ClareJohn R Hodges
Sep 14, 2004·American Journal of Alzheimer's Disease and Other Dementias·E AgugliaE Maso
Apr 26, 2005·Aging Clinical and Experimental Research·Martina MarvardiUNKNOWN Italian Society of Gerontology and Geriatrics
May 28, 2005·International Journal of Geriatric Psychiatry·Linda GarandCharles F Reynolds
Aug 17, 2005·Dementia and Geriatric Cognitive Disorders·A BizzarroC Masullo
Aug 30, 2005·Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists·Sophie BaudicLatchezar Traykov
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Oct 26, 2005·Human Brain Mapping·Eric SalmonGaëtan Garraux
Nov 2, 2005·The British Journal of Psychiatry : the Journal of Mental Science·Graziano OnderRoberto Bernabei
Apr 25, 2006·Lancet·Serge GauthierUNKNOWN International Psychogeriatric Association Expert Conference on mild cognitive impairment
May 10, 2006·Dementia and Geriatric Cognitive Disorders·Jette StokholmGunhild Waldemar
May 17, 2006·Aging Clinical and Experimental Research·Maria CotelliOrazio Zanetti
Jun 20, 2006·Lancet·Peter Whitehouse, Henry Brodaty
Sep 7, 2006·International Journal of Geriatric Psychiatry·Giovanni B FrisoniValeria Zacchi
Oct 21, 2006·Lancet Neurology·Silvia SörensenMartin Pinquart

❮ Previous
Next ❯

Citations

Dec 24, 2014·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·A PetrelliE Kalbe
Mar 31, 2015·Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition·Julia RaheElke Kalbe
May 21, 2016·Frontiers in Aging Neuroscience·Sara MondiniDaniela Mapelli
Jul 26, 2018·American Journal of Alzheimer's Disease and Other Dementias·Nélia Sofia DominguesCarol Hudon
May 17, 2019·Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition·Mandy RohegerElke Kalbe
Jul 1, 2019·NeuroRehabilitation·Sara BerniniElena Sinforiani
Aug 31, 2016·World Journal of Clinical Cases·Agnès Weill-ChounlamountryPascale Pradat-Diehl
Jun 18, 2019·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Mandy RohegerElke Kalbe

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.